AMBER HOBERG: Open Payments
NPI 1003122532 · FLORESVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$438,734 in 559 payments from 14 companies in 2025. Trend: 2023 $426,616 · 2024 $460,258 · 2025 $438,734
Speaker / faculty: $265,096Consulting: $76,726Travel & lodging: $53,652Honoraria: $31,888Food & beverage: $11,271Education: $101
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 170 | $169,518 |
| E.R. Squibb & Sons, L.L.C. | 116 | $123,507 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 89 | $46,674 |
| Axsome Therapeutics, Inc. | 58 | $36,772 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 21 | $25,578 |
| Neurocrine BioSciences, Inc. | 41 | $19,463 |
| Alkermes, Inc. | 32 | $15,269 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $900 |
| ACADIA Pharmaceuticals Inc | 4 | $521 |
| ABBVIE INC. | 16 | $227 |
Products named: AUSTEDO XR, COBENFY, UZEDY, CAPLYTA, Auvelity, INGREZZA, LYBALVI, REXULTI.
Industry payments across TX — which companies pay providers there.
